June 10, 2008 – The design of the University of Chicago Medical Center’s New Hospital Pavilion offers flexibility by ...
June 13, 2008 - The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit ...
Biomarkers are key indicators for pharmaceutical companies in determining which types of drugs to develop for various ...
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
June 10, 2008 – MEDSEEK, a provider of enterprise portal management solutions, said today it is supporting Microsoft ...
June 10, 2008 - At the Digestive Disease Week Conference, Cook Medical announced that it has been granted 510(k) clearance from the FDA for use of the Evolution Controlled Release Esophageal Stent System, a stent designed to improve the quality of life for patients with esophageal cancer.
Cook Medical's FDA-cleared Evolution Controlled Release Esophageal Stent System is a stent designed to improve the quality of life for patients with esophageal cancer.
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and ...
June 9, 2008 – American TeleCare Inc. (ATI) released Quick Notes as a new feature of its inLife/LifeView Telehealth ...
June 9, 2008 - The FDA cleared Mindray’s DC-3 color ultrasound imaging system, equipped with extensive applications in ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
Candelis received 510(k) marketing clearance for its ImageGrid Mammography Web Viewer and ImageGrid Radiology Web Viewer ...
Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer Microspheres for Injectable Suspension), an ultrasound imaging agent for the detection of coronary artery disease, which could prove as accurate as nuclear stress testing.
With radiologists in short supply, the need for teleradiology services continues to grow and the market has responded in ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 9, 2008 - Cardinal Health today launched a new system that leverages the company’s dispensing technologies to ...
June 9, 2008 - Hologic Inc. said today that it has signed a definitive agreement to acquire Third Wave Technologies Inc ...
Toshiba Teli America introduced the T24MSA001-MD medical-grade 24-inch LCD color widescreen monitor with full HD (1,080 ...
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
June 09, 2008 